Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Protocols for Dental Implant Surgery
NCT06378502Phase 4Not yet recruiting
- Sponsor
- University of Genoa
- Start
- May 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of amoxicillin in surgical site infection (SSI) (2 arms), sponsored by University of Genoa. Primary endpoint: Mean peri-implant bone loss at 12 months. Planned start May 2024; status: not yet recruiting.
02
Drugs
amoxicillin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT06378502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06378502.